Analysis for nitrosourea antitumor agents by gas chromatography--mass spectrometry. - Suppr | 超能文献

Analysis for nitrosourea antitumor agents by gas chromatography--mass spectrometry.

作者信息

Smith R G, Blackstock S C, Cheung L K, Loo T L

出版信息

Anal Chem. 1981 Jul;53(8):1205-8. doi: 10.1021/ac00231a017.

DOI:10.1021/ac00231a017

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Analysis for nitrosourea antitumor agents by gas chromatography--mass spectrometry.

Anal Chem. 1981 Jul;53(8):1205-8. doi: 10.1021/ac00231a017.

2

Determination of two nitrosourea antitumor agents by chemical ionization gas chromatography--mass spectrometry.化学电离气相色谱-质谱法测定两种亚硝基脲类抗肿瘤药物

J Chromatogr. 1982 May 14;229(2):464-9. doi: 10.1016/s0378-4347(00)84292-9.

3

Nitroimidazoles as modifiers of nitrosourea pharmacokinetics.作为亚硝基脲类药物药代动力学修饰剂的硝基咪唑类药物。

Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1627-30. doi: 10.1016/0360-3016(84)90516-9.

4

Lipophilic drugs and lipoproteins: partitioning effects on chloroethylnitrosourea reaction rates in serum.亲脂性药物与脂蛋白：血清中对氯乙基亚硝脲反应速率的分配效应

J Pharmacol Exp Ther. 1980 Aug;214(2):318-23.

5

Pharmacology of the nitrosoureas: an overview.亚硝基脲类药物药理学概述

Cancer Treat Rep. 1976 Jun;60(6):703-7.

6

Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.1-(2-氯乙基)-3-(2,6-二氧代-1-哌啶基)-1-亚硝基脲在大鼠和患者体内的比较药代动力学及向临床试验的外推

Cancer Res. 1981 Sep;41(9 Pt 1):3475-7.

7

Determination of tauromustine, a nitrosourea-based antitumour agent, in plasma by high-performance liquid chromatography.

J Chromatogr. 1988 Mar 18;425(2):424-8. doi: 10.1016/0378-4347(88)80050-1.

8

Nitrosourea pharmacodynamics in relation to the central nervous system.亚硝基脲类药物与中枢神经系统相关的药效学

Cancer Treat Rep. 1976 Jun;60(6):725-8.

9

Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry.采用负化学电离质谱法测定血浆中1-(2-氯乙基)-3-(2,6-二氧代-3-哌啶基)-1-亚硝基脲

Biomed Mass Spectrom. 1983 Jul;10(7):404-7. doi: 10.1002/bms.1200100704.

10

Mechanism of action of (2-haloethyl)nitrosoureas on DNA. Isolation and reactions of postulated 2-(alkylimino)-3-nitrosooxazolidine intermediates in the decomposition of 1,3-bis(2-chloroethyl)-, 1-(2-chloroethyl)-3-cyclohexyl-, and 1-(2-chloroethyl)-3-(4'-trans-methylcyclohexyl)-1-nitrosourea.（2-卤代乙基）亚硝基脲对DNA的作用机制。1,3-双（2-氯乙基）-、1-（2-氯乙基）-3-环己基-和1-（2-氯乙基）-3-（4'-反式甲基环己基）-1-亚硝基脲分解过程中假定的2-（烷基亚氨基）-3-亚硝基恶唑烷中间体的分离与反应。

J Med Chem. 1981 Mar;24(3):270-9. doi: 10.1021/jm00135a007.

引用本文的文献

1

Predicted and actual BCNU concentrations in normal rabbit brain during intraarterial and intravenous infusions.

J Neurooncol. 1996 Oct;30(1):7-18. doi: 10.1007/BF00177438.

2

Capillary gas chromatography and thermionic N-P-specific detection of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) or 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in stability and pharmacokinetic studies.在稳定性和药代动力学研究中，采用毛细管气相色谱法和热离子氮磷特异性检测法测定1,3-双（2-氯乙基）-1-亚硝基脲（卡莫司汀）或1-（2-氯乙基）-3-环己基-1-亚硝基脲（洛莫司汀）。

Pharm Res. 1988 Apr;5(4):220-5. doi: 10.1023/a:1015989612562.